Washington Post, December 11, 2017
Lena H. Sun and Alice Crites

Links

Read the Full Article

ATLANTA — After five months in office, President Trump’s new director of the Centers for Disease Control and Prevention has been unable to divest financial holdings that pose potential conflicts of interest, hindering her ability to fully perform her job.

Brenda Fitzgerald, 71, who served as the Georgia public health commissioner until her appointment to the CDC post in July, said she has divested from many stock holdings. But she and her husband are legally obligated to maintain other investments in cancer detection and health information technology, according to her ethics agreement, requiring Fitzgerald to pledge to avoid government business that might affect those interests. Fitzgerald provided The Post with a copy of her agreement.

Last week, Sen. Patty Murray (Wash.), the senior Democrat on the Senate committee that oversees CDC, wrote that Fitzgerald is raising questions about her ability to function effectively. [...]

bioethics public health regulation